Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1970 1
1971 4
1972 3
1973 7
1974 8
1975 8
1977 2
1978 1
1979 1
1980 1
1983 1
1984 4
1985 1
1986 3
1988 1
1989 7
1990 1
1991 3
1992 3
1993 2
2000 1
2004 3
2005 2
2006 4
2007 4
2008 2
2009 3
2010 1
2011 1
2013 2
2024 0

Text availability

Article attribute

Article type

Publication date

Search Results

84 results

Results by year

Filters applied: . Clear all
Page 1
[Changes in weight and diabetes compensation (HbA(1c)) in patients with diabetes mellitus type 2 after adding exenatide (Byetta) to the current treatment in 28 diabetology departments in the Czech Republic - BIBY-I study (observations lasting 3 to 12 months)].
Perusicová J, Haladová I, Pit'hová P, Acsová D, Belobrádková J, Belzová A, Berková K, Dolezalová B, Dvoráková H, Hejnicová K, Hudcová M, Kallmünzerová D, Krejsová Z, Markofová G, Müllerová H, Owen K, Pelikánová M, Raclavská L, Racická E, Skarpová O, Váchová A, Veselá A, Vyoralos J, Broz J, Edelsberger T, Honka M, Hrdina T, Chmura P, Tosovský J. Perusicová J, et al. Among authors: tosovsky j. Vnitr Lek. 2013 Mar;59(3):165-71. Vnitr Lek. 2013. PMID: 23713182 Czech.
[Changes in weight and diabetes compensation (HbA1c) in patients with diabetes mellitus type 2 after adding exenatide (Byetta) to the current treatment in 28 diabetology departments in the Czech Republic -  BIBYII study (observations lasting 24 months)].
Perušičová J, Piťhová P, Haladová I, Diabetologů AP, Acsová D, Bělobrádková J, Belzová A, Berková K, Doležalová B, Dvořáková H, Hejnicová K, Hudcová M, Kallmünzerová D, Krejsová Z, Markofová G, Müllerová H, Owen K, Pelikánová M, Raclavská L, Račická E, Skarpová O, Váchová A, Veselá A, Vyoralová J, Brož J, Edelsberger T, Honka M, Hrdina T, Chmura P, Tosovsky J. Perušičová J, et al. Among authors: tosovsky j. Vnitr Lek. 2013 Apr;59(4):249-55. Vnitr Lek. 2013. PMID: 23711049 Czech.
Percutaneous coronary intervention versus coronary-artery bypass grafting for severe coronary artery disease.
Serruys PW, Morice MC, Kappetein AP, Colombo A, Holmes DR, Mack MJ, Ståhle E, Feldman TE, van den Brand M, Bass EJ, Van Dyck N, Leadley K, Dawkins KD, Mohr FW; SYNTAX Investigators. Serruys PW, et al. N Engl J Med. 2009 Mar 5;360(10):961-72. doi: 10.1056/NEJMoa0804626. Epub 2009 Feb 18. N Engl J Med. 2009. PMID: 19228612 Free article. Clinical Trial.
84 results